MFIM
NAMS icon

Mesirow Financial Investment Management’s NewAmsterdam Pharma NAMS Stock Holding History

Mesirow Financial Investment Management’s Portfolio NAMS Stock Details NAMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$253K Sell
7,465
-7,965
-52% -$262K ﹤0.01% 469
2026
Q1 		$494K Buy
15,430
+7,215
+88% +$235K 0.01% 364
2025
Q4 		$288K Hold
8,215
– – 0.01% 411
2025
Q3 		$234K Buy
+8,215
New +$197K ﹤0.01% 502

Other funds holding NAMS

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
MMC
Mizuho Markets Cayman Grand Cayman, Cayman Islands $2.67B AUM 103.47% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.79B AUM 30.56% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
MAP
Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Mesirow Financial Investment Management's NAMS Position: Q2 2026 in Review

Mesirow Financial Investment Management reduced its NewAmsterdam Pharma (NAMS) stake by 52% in Q2 2026, selling an estimated $262K and leaving 7,465 shares worth $253K. The position accounts for ﹤0.01% of the portfolio, ranked #469.

Mesirow Financial Investment Management first reported a position in NAMS in Q3 2025 and has held it in 4 quarters since. The position peaked at $494K in Q1 2026. 31 funds tracked by Wall St. Rank hold NAMS as of Q2 2026.

  • Mesirow Financial Investment Management held 7,465 shares of NewAmsterdam Pharma worth $253K as of Q2 2026.
  • Mesirow Financial Investment Management sold 7,965 NewAmsterdam Pharma shares in Q2 2026, an estimated $262K.
  • NewAmsterdam Pharma made up ﹤0.01% of Mesirow Financial Investment Management's portfolio in Q2 2026, its #469 holding.
  • Mesirow Financial Investment Management first reported a position in NewAmsterdam Pharma in Q3 2025 and has held it in 4 quarters since.
  • Mesirow Financial Investment Management's NewAmsterdam Pharma position peaked at $494K in Q1 2026.
  • 31 funds tracked by Wall St. Rank held NewAmsterdam Pharma as of Q2 2026.

Based on Mesirow Financial Investment Management's 13F filing for Q2 2026, filed 22 Jul 2026.